Skip to main content
. 2022 Feb 15;14(4):810. doi: 10.3390/nu14040810

Table 5.

Pre-specified maternal metabolic profiles at 36–38 weeks gestation for intervention and control groups based on fasting blood samples.

Group Mean (SD)
Median (Q1, Q3) 1
Intervention Effect
Complete Case Analysis ITT Analysis
Metabolite Intervention
n = 119
Control
n = 122
Mean Difference
(95% CI)
p Mean
Difference
(95% CI)
p
Glucose, mmol/L 4.6
(0.5)
4.6
(0.5)
−0.04
(−0.17, 0.08)
0.481 −0.02
(−0.16, 0.12)
0.787
Missing 31 26 61
HDL, mmol/L 1.88
(0.44)
1.87
(0.46)
−0.03
(−0.12, 0.07)
0.601 −0.02
(−0.12, 0.09)
0.759
Missing 30 28 62
LDL, mmol/L 4.00
(1.11)
4.17
(1.09)
−0.31
(−0.57, −0.06)
0.015 −0.24
(−0.50, 0.02)
0.073
Missing 31 30 66
Triglycerides,
mmol/L
2.53
(0.80)
2.66
(0.79)
−0.18
(−0.36, 0.01)
0.062 −0.16
(−0.38, 0.07)
0.172
Missing 30 28 62
Total cholesterol, mmol/L 7.03
(1.38)
7.26
(1.33)
−0.41
(−0.72, −0.09)
0.012 −0.29
(−0.62, 0.05)
0.096
Missing 30 28 62
Insulin, pmol/L 52.08
(34.06, 82.36)
47.95
(32.16, 74.31)
<0.01
(−0.15, 0.15) 2
0.999 −0.04
(−0.21, 0.13) 2
0.633
Missing 27 25 56
Leptin, ng/mL 29.83
(15.97, 49.35)
30.32
(15.47, 54.63)
−1.37
(−6.67, 3.92)
0.609 −0.94
(−8.56, 6.68) 2
0.805
Missing 26 25 54
Adiponectin, ug/mL 6.97
(2.62)
7.32
(3.21)
0.02
(−0.55, 0.58)
0.956 −0.05
(−0.97, 0.87)
0.915
Missing 26 25 54
CRP, mg/L 4.29
(2.39, 7.37)
4.53
(1.92, 7.36)
0.21
(<0.01, 0.42) 2
0.046 −0.11
(−0.33, 0.55) 2
0.600
Missing 26 25 55

1 Descriptive statistics for continuous outcome I are presented using medians and quartiles (Q1 and Q3). 2 Regression analysis based on natural log (ln) transformation of outcome. All analyses adjusted for site (Hamilton, London) and pre-pregnancy BMI categories: underweight to normal weight (BMI ≤ 24.9), overweight (BMI = 25.0–29.9), obese (BMI = 30.9). Underweight and normal weight were grouped together due to a low number of observations in the underweight category (n = 4).